0001127602-20-022089.txt : 20200724
0001127602-20-022089.hdr.sgml : 20200724
20200724162454
ACCESSION NUMBER: 0001127602-20-022089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200723
FILED AS OF DATE: 20200724
DATE AS OF CHANGE: 20200724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benjamin Eric
CENTRAL INDEX KEY: 0001731734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 201047167
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 600 TECHNOLOGY PARK DR, SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-07-23
0001145197
INSULET CORP
PODD
0001731734
Benjamin Eric
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
SVP, Innovation and Strategy
Common Stock
2020-07-23
4
S
0
6520
210.00
D
8704
D
Common Stock
2020-07-23
4
M
0
1396
30.02
A
10100
D
Common Stock
2020-07-23
4
M
0
6996
29.26
A
17096
D
Common Stock
2020-07-23
4
S
0
8392
210.00
D
8704
D
Employee Stock Option (Right to Buy)
30.02
2020-07-23
4
M
0
1396
0
D
2025-07-01
Common Stock
1396
0
D
Employee Stock Option (Right to Buy)
29.26
2020-07-23
4
M
0
6996
0
D
2026-02-24
Common Stock
6996
0
D
The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
Includes 107 shares acquired under the Insulet Corporation Stock Purchase Plan on May 29, 2020.
This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
/s/ John W. Kapples, attorney-in-fact
2020-07-24